Literature DB >> 12140759

Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation.

Miranda Thomas1, Richard Laura, Karin Hepner, Ernesto Guccione, Charles Sawyers, Laurence Lasky, Lawrence Banks.   

Abstract

The E6 proteins from the high-risk human papillomavirus (HPV) types have previously been shown to target a number of PDZ domain-containing proteins for proteasome-mediated degradation. These include the hDlg tumour suppressor and the MAGI-1 protein. In this study we show that high-risk HPV E6 proteins also target the related MAGI-2 and MAGI-3 proteins for degradation. Moreover, we show that the interaction is specific to one PDZ domain, and that co-expression of this domain can protect each of the full-length MAGI proteins from E6-mediated degradation. These data provide clear indicators for the potential design of compounds that could specifically inhibit the interaction of oncogenic HPV E6 proteins with an important class of target proteins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12140759     DOI: 10.1038/sj.onc.1205668

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  86 in total

1.  Evolution of metazoan cell junction proteins: the scaffold protein MAGI and the transmembrane receptor tetraspanin in the demosponge Suberites domuncula.

Authors:  Teresa Adell; Vera Gamulin; Sanja Perović-Ottstadt; Matthias Wiens; Michael Korzhev; Isabel M Müller; Werner E G Müller
Journal:  J Mol Evol       Date:  2004-07       Impact factor: 2.395

Review 2.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

Review 3.  Tight junctions in the testis: new perspectives.

Authors:  Dolores D Mruk; C Y Cheng
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-05-27       Impact factor: 6.237

4.  Viral oncoprotein-induced mislocalization of select PDZ proteins disrupts tight junctions and causes polarity defects in epithelial cells.

Authors:  Isabel J Latorre; Michael H Roh; Kristopher K Frese; Robert S Weiss; Ben Margolis; Ronald T Javier
Journal:  J Cell Sci       Date:  2005-09-01       Impact factor: 5.285

5.  Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31.

Authors:  Choongho Lee; Laimonis A Laimins
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

Review 6.  Epithelial cell polarity and tumorigenesis: new perspectives for cancer detection and treatment.

Authors:  Danila Coradini; Claudia Casarsa; Saro Oriana
Journal:  Acta Pharmacol Sin       Date:  2011-04-18       Impact factor: 6.150

Review 7.  Papillomavirus E6 oncoproteins.

Authors:  Scott B Vande Pol; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-05-24       Impact factor: 3.616

Review 8.  Emerging theme: cellular PDZ proteins as common targets of pathogenic viruses.

Authors:  Ronald T Javier; Andrew P Rice
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

9.  Human and primate tumour viruses use PDZ binding as an evolutionarily conserved mechanism of targeting cell polarity regulators.

Authors:  V Tomaić; D Gardiol; P Massimi; M Ozbun; M Myers; L Banks
Journal:  Oncogene       Date:  2008-09-29       Impact factor: 9.867

10.  Biomarkers in cervical cancer.

Authors:  Eun-Kyoung Yim; Jong-Sup Park
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.